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To The Editor: Women with primary 
hypothyroidism may have either oligo- , or 
amenorrhea, or menorrhagia. These menstrual 
changes often result in decreased fertility. If 
pregnancy does occur there is an increased 
likelihood for early abortion or premature labor [1]. 
Post term pregnancies (PP) have not been 
reported before. However, it has been 
hypothesized that prolonged pregnancy is a 
possible complication of hypothyroidism due to 
some sort of myometriopathy [2]. 
 
Case report 
A pregnant Libyan patient, 37 years old, gravida 
10 , para 9 with a history of one previous 
caesarean section (because of antepartum 
hemorrhage), previously healthy and under regular 
antenatal follow up, presented on her 39
th week of 
pregnancy with one month’s history of gradually 
worsening lower limbs weakness and aching pain, 
which became worse in the last week. 
On examination she was looking well with pink 
cheeks, the power at hips and knees was 4/5, both 
on flexion and extension with tenderness over the 
two quadriceps muscles and a delayed relaxation 
phase of the deep tendon jerks at the ankles.     
Gower’s sign was positive . The power at the 
ankles and at the upper limbs was normal, the 
sensory examinations were also normal. 
Laboratory findings: creatinine phosphokinase 
(CPK):82 U/L, S.Ca2+: 8.2 mg/dl, S.K+: 
4.7mmol/L, alkaline phosphatase: 337U/L, thyroid 
stimulating hormone (TSH) >100 mIU/L (0.47-4.68 
mIU/L), FT4: 7.9 pmol/L (12-22 pmol/L) FBS: 
55mg/dl. The neck ultrasonography showed a 
normal size thyroid with low echogenesity, and a 
nine millimeters nodule at the left lobe. Anti thyroid 
peroxidase (anti-TPO) antibodies were >600 IU/ml.  
Based on the above findings she was diagnosed 
as a case of hypothyroid myopathy and  was 
started on 100ug L-thyroxin daily but after 3weeks 
she was still having the same complaint with the 
same examination findings and she was already 
post term (42 weeks + 1day) , and this was the 
first time for her to have a prolonged pregnancy. 
She was subjected to an elective caesarean 
section in the next day along with tubal ligation, 
and she delivered a normal male baby weighing 
3Kgs who had a normal thyroid function test. 
Three weeks later she was seen in the 
endocrinology clinic. She was feeling well and her 
neurological examination was almost normal with 
normal power and reflexes. Her TSH was 8 m IU/L 
so the L-thyroxin dose was increased to 
125ug/day.   
 
Discussion 
The standard internationally-recommended 
definition of prolonged pregnancy, endorsed by 
the American college of obstetricians and 
gynecologists (1997), is 42 completed weeks (294 
days) or more from the first day of the last 
menstrual period. A variety of maternal 
demographic features such as parity, prior post 
term birth, socioeconomic class, and age have 
been suggested as  predisposing risk factors to 
post term pregnancy, and some authors 
suggested that some prolonged pregnancies are 
biologically determined [3]. 
Although the post term pregnancy in this 
hypothyroid patient with myopathy could be just a 
coincidence, we think that the association in this 
particular case is more than incidental for many 
reasons, including:  
1- Animal studies demonstrate that thyroid 
hormone is necessary for expression of the genes 
for fast myofibrillar proteins. Both an increase in 
the concentration of slow myofibrillar proteins and 
alterations in the myosin composition of myofibrils 
have been found in hypothyroid rats [4]. This may 
contribute to the weakness associated with 
hypothyroidism.  
Also animal studies suggest that the sluggish 
muscle contraction may be related to decreased 
myosin ATPase activity and alterations in sodium 
and potassium transport across the sarcolemmal 
membrane; [5,6]. 
Although these effects were studied in skeletal 
muscles, generalizing them to include the smooth 
muscles is possible as the actin and myosin 
filaments of the smooth muscles have chemical 
characterestics similar to those in the skeletal 
muscles. Moreover, chemical studies have shown 
that smooth muscles` actin and myosin interact 
with each other in much the same way as that 
occurring in skeletal muscles. Furthermore, the 
contractile process in smooth muscles is also 
activated by calcium ions, and adenosine 
triphosphate (ATP) to provide the energy for 
contraction [7] 
2- It has been shown that hypothyroidism 
significantly reduces the amplitude and frequency 
of spontaneous rhythmic contractions of rats’ 
myometrium [8]. 
3- The parathyroid hormone (PTH) is raised in 
hypothyroidism [1], and PTH may act on 
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myometrial smooth muscles to facilitate the 
maintenance of uterine tranquility [9].  
4- Prostaglandins including (PGE2) are among 
multiple mediators involved in the onset of human 
labor [9], it has been shown that there is a 
decreased PGE2 production in the kidneys of 
hypothyroid rats [10]. 
5- Endothelins are very powerful inducers of 
myometrial contraction while nitric oxide causes 
myometrial relaxation [9], hypothyroidism causes 
both an increase in nitric oxide levels and 
reduction in endothelin levels [11].  
6- Platelet-activating factor (PAF) promotes 
uterine contraction and it is inactivated 
enzymatically by PAF-acetylhydrolase [9]. Patients 
with hypothyroidism exhibit an increased activity of 
PAF-acetylhydrolase, hence more PAF 
inactivation [12]. 
7- Angiotensin-II is another uterotonin that 
promotes increased myometrial cell [ca++] thus 
promoting uterine contraction [9]. The plasma level 
of angiotensin-II is reduced by 81% in hypothyroid 
rats [13].                    
8- Human chorionic gonadotropin (HCG) acts to 
activate adenylcyclase via a plasma receptor-G 
alpha S-linked system and this causes a decrease 
in the frequency and force of  uterine contraction 
[9], in view of the fact that there is a close 
structural relationship between TSH and HCG and 
their receptors [14], and since it was demonstrated 
that HCG can stimulate TSH receptors [15] and 
increase thyroid hormone secretion, it would be 
possible that TSH (particularly in high levels as in 
primary hypothyroidism) also can stimulate HCG 
receptors and reduce the uterine contractions in 
the same manner.   
From all the previous evidence that clearly 
demonstrates the reduction in mechanisms that 
facilitate uterine contraction and augmentation of 
mechanisms that promote uterine quiescence in 
hypothyroid state, it may be concluded that 
primary hypothyroidism during pregnancy might be 
complicated by a prolonged gestation, a 
complication that had never been described before 
with hypothyroidism. However most of the previous 
findings are derived from animal studies and the 
stated changes in hypothyroidism should also be 
proved in human studies both in laboratory and 
clinical situations. 
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